Search research articles
Contact Us
Filters
Showing results (1-10 of 68) with videos related to
Page
of 7
Sort By:
Journal of Neuroendocrinology
|
November 12, 2024
Somatostatin receptor-linked α-particle therapy in neuroendocrine tumours
Shaunak Navalkissoor, Ashley Grossman
Neuroendocrinology
|
October 24, 2018
Targeted Alpha Particle Therapy for Neuroendocrine Tumours: The Next Generation of Peptide Receptor Radionuclide Therapy
Shaunak Navalkissoor, Ashley Grossman
Clinical Medicine (London, England)
|
August 31, 2012
Molecular radiotherapy
John Buscombe, Shaunak Navalkissoor
Journal of Neuroendocrinology
|
March 2, 2025
Peptide receptor radionuclide therapy (PRRT) special issue
Shaunak Navalkissoor, Robert P Millar
Nuclear Medicine Communications
|
January 27, 2011
The continuing evolution of somatostatin receptor imaging in neuroendocrine tumours
Shaunak Navalkissoor, John R Buscombe
Seminars in Nuclear Medicine
|
August 12, 2025
The Role of [177Lu] Lu-Satoreotide Tetraxetan in Somatostatin Receptor-Positive Neuroendocrine Tumors
Kalyan Mansukhbhai Shekhda, Shaunak Navalkissoor
Nuclear Medicine Communications
|
July 31, 2010
Functional lung assessment with radionuclides in paediatric respiratory diseases: a useful, underutilized test in nuclear medicine?
Shaunak Navalkissoor, Marina Easty, Lorenzo Biassoni
The British Journal of Radiology
|
August 14, 2018
Theranostics in neuroendocrine tumours: somatostatin receptor imaging and therapy
Deborah Pencharz, Gopinath Gnanasegaran, Shaunak Navalkissoor
Clinical Medicine (London, England)
|
October 5, 2017
Molecular radiotheranostics for neuroendocrine tumours
Shaunak Navalkissoor, Glenn Flux, Jamshed Bomanji
BMJ Case Reports
|
September 24, 2015
Neurological symptoms from a brain metastasis as the first presentation of colorectal cancer
Christina Chu, Shaunak Navalkissoor, Roopinder Gillmore
Page
of 7
Search research articles
Search
Showing results (1-10 of 68) with videos related to
Sort By:
Page
of 7
Journal of Neuroendocrinology
|
November 12, 2024
Somatostatin receptor-linked α-particle therapy in neuroendocrine tumours
Shaunak Navalkissoor, Ashley Grossman
Neuroendocrinology
|
October 24, 2018
Targeted Alpha Particle Therapy for Neuroendocrine Tumours: The Next Generation of Peptide Receptor Radionuclide Therapy
Shaunak Navalkissoor, Ashley Grossman
Clinical Medicine (London, England)
|
August 31, 2012
Molecular radiotherapy
John Buscombe, Shaunak Navalkissoor
Journal of Neuroendocrinology
|
March 2, 2025
Peptide receptor radionuclide therapy (PRRT) special issue
Shaunak Navalkissoor, Robert P Millar
Nuclear Medicine Communications
|
January 27, 2011
The continuing evolution of somatostatin receptor imaging in neuroendocrine tumours
Shaunak Navalkissoor, John R Buscombe
Seminars in Nuclear Medicine
|
August 12, 2025
The Role of [177Lu] Lu-Satoreotide Tetraxetan in Somatostatin Receptor-Positive Neuroendocrine Tumors
Kalyan Mansukhbhai Shekhda, Shaunak Navalkissoor
Nuclear Medicine Communications
|
July 31, 2010
Functional lung assessment with radionuclides in paediatric respiratory diseases: a useful, underutilized test in nuclear medicine?
Shaunak Navalkissoor, Marina Easty, Lorenzo Biassoni
The British Journal of Radiology
|
August 14, 2018
Theranostics in neuroendocrine tumours: somatostatin receptor imaging and therapy
Deborah Pencharz, Gopinath Gnanasegaran, Shaunak Navalkissoor
Clinical Medicine (London, England)
|
October 5, 2017
Molecular radiotheranostics for neuroendocrine tumours
Shaunak Navalkissoor, Glenn Flux, Jamshed Bomanji
BMJ Case Reports
|
September 24, 2015
Neurological symptoms from a brain metastasis as the first presentation of colorectal cancer
Christina Chu, Shaunak Navalkissoor, Roopinder Gillmore
Page
of 7